Cancer Incidence and Etiology in the Active Duty Population of U.S. Military
Military Medicine · 23.01.2024 · 189 (1-2) · e58-e65
DOI: 10.1093/milmed/usac297 ↗Kurz gefasst
Fachartikel in der Zeitschrift Military Medicine, online erschienen am 14.10.2022. Verfasst von Leann A Lovejoy und 2 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Breast Care Project, Chan Soon-Shiong Institute for Molecular Medicine at Windber, Windber, PA 15963, USA. Hauptthemen laut MEDLINE: Testicular Neoplasms, Military Personnel, Melanoma. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 54 Literaturangaben. Gefördert von: Uniformed Services University of the Health Sciences.
Abstract (Originalsprache)
Introduction
As members of the military, all active duty service members (ADS) must meet physical fitness requirements and are provided with equal-access healthcare through the DoD. In addition, 92% of ADS are ≤40 years of age. Together, these characteristics suggest that ADS represent a healthy population that may have a low risk of cancer. Each year, however, >800 ADS are diagnosed with cancer and the resulting in time off for treatment, reassignment, or medical retirement may significantly impact force readiness. Material and Methods Relevant literature was identified by searching the PubMed database using search terms ACTIVE DUTY and CANCER. Only articles written in English were included.
Results
Melanoma is the most common cancer in ADS, while testicular cancer is the most common cancer in males and breast cancer is the most common in females. Cancer incidence patterns in ADS differ from those in the general U.S. population and from military veterans. Tumor etiology in ADS may be influenced by military-enriched exposures such as prolonged use of oral contraceptives, suboptimal use of sunscreen, exposure to volatile organic compounds, or germline predisposition/family history.
Conclusions
The etiology of cancer within ADS remains largely unknown. A number of new research programs may provide the means to improve understanding of the etiology of cancer in ADS. Together, these efforts will improve prevention, early detection, and clinical management, thus improving the outcomes of ADS and preserving force readiness.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Clinical Breast Care Project, Chan Soon-Shiong Institute for Molecular Medicine at Windber, Windber, PA 15963, USA.
- Murtha Cancer Center Research Program, Department of Surgery, Uniformed Services University of the Health Sciences, Bethesda, MD 20889, USA.
- Henry M. Jackson Foundation for the Advancement of Military Medicine, Windber, PA 15963, USA.
ORCID-Profile: Rachel E Ellsworth
Förderung
- Uniformed Services University of the Health Sciences
Zitieren
APA
Lovejoy, L. A., Shriver, C. D., & Ellsworth, R. E. (2024). Cancer Incidence and Etiology in the Active Duty Population of U.S. Military. Military Medicine, 189(1-2), e58-e65. https://doi.org/10.1093/milmed/usac297
Vancouver
Lovejoy LA, Shriver CD, Ellsworth RE. Cancer Incidence and Etiology in the Active Duty Population of U.S. Military. Military Medicine. 2024;189(1-2):e58-e65. doi:10.1093/milmed/usac297
BibTeX
@article{Lovejoy2024,
author = {Lovejoy, Leann A and Shriver, Craig D and Ellsworth, Rachel E},
title = {Cancer Incidence and Etiology in the Active Duty Population of U.S. Military},
journal = {Military Medicine},
year = {2024},
volume = {189},
number = {1-2},
pages = {e58--e65},
doi = {10.1093/milmed/usac297}
}
EUVIMED